Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Survival in Medically Treated Patients with Homozygous β-Thalassemia
- N. Olivieri, D. Nathan, +6 authors A. Cohen
- Medicine
- 1 September 1994
Background The prognosis of patients with homozygous β-thalassemia (thalassemia major) has been improved by transfusion and iron-chelation therapy. We analyzed outcome and prognostic factors among… Expand
Cambodia: A Shattered Society
- D. Chandler, M. Martin, Mark W. Mcleod
- History
- 11 July 1994
The history of modern Cambodia has been one of invasion, occupation, political chaos, and genocidal terror. Marie Martin traces the evolution of post-World War II Cambodian politics and society,… Expand
Current Treatment of Cooley's Anemia
- A. Cohen, M. Martin, E. Schwartz
- Medicine
- 1 December 1990
Two major themes have run through the discussion of iron chelation therapy at the three previous Cooley’s Anemia Symposia. First, with the passage of time, the benefits of regular administration of… Expand
1169 HEALTH-RELATED QUALITY-OF-LIFE AMONG GENOTYPE 1 TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS RECEIVING TELAPREVIR COMBINATION TREATMENT: POST-HOC ANALYSES OF DATA FROM THE ADVANCE TRIAL
- Z. Younossi, J. Aggarwal, +5 authors M. Vera-Llonch
- Medicine
- 1 April 2012
Health-related quality of life of heart failure and coronary artery disease patients improved during participation in disease management programs: a longitudinal observational study.
- M. Martin, Bonnie Blaisdell-Gross, +6 authors J. Ware
- Medicine
- Disease management : DM
- 22 June 2007
The objective of the study was to examine the burden of coronary artery disease (CAD) and heart failure (HF) on health-related quality of life (HRQOL) and the HRQOL trajectory among participants in a… Expand
904 HEALTH-RELATED QUALITY-OF-LIFE AMONG GENOTYPE 1 TREATMENT-EXPERIENCED CHRONIC HEPATITIS C PATIENTS: POST-HOC ANALYSES FROM THE REALIZE STUDY
- K. Sherman, A. Muir, +5 authors Z. Younossi
- Medicine
- 1 April 2013
did not return baseline until Week 60. Over the entire study, fatigue was lower for simeprevir-treated patients than controls (p < 0.001). EQ5D-VAS plots showed an expected inverse trend to FSS. FSS… Expand
Telaprevir in Combination with Peginterferon Alfa-2a and Ribavirin Increased Sustained Virologic Response in Genotype 1 Chronic HCV and Allowed for Shorter Treatment Duration in Treatment-naive and…
- G. Everson, G. Dusheiko, +13 authors S. Zeuzem
- Medicine
- 1 October 2011
S-band amplifier with variable gain tilt control
- I. Clarke, M. Meleshkevich, M. Martin, J. Poirier
- Materials Science
- OFC . Optical Fiber Communication Conference and…
- 17 March 2001
We present a method of variable gain tilt control for a thulium doped fiber amplifier (TDFA) using a mid-stage attenuator, together with measurements of the amplifier performance. The addition of… Expand
Phenomenon of Pain In Thalassemia: A Prospective Analysis by the Thalassemia Clinical Research Network (TCRN)
- Dru Haines, S. Carson, +17 authors F. Trachtenberg
- Medicine
- 19 November 2010
Abstract 256 Background: Pain is not a symptom generally associated with thalassemia. However, healthcare providers have anecdotally noted increasing patient reports of chronic pain over the last… Expand
...
1
2
...